← back to search

Hongyan Zhang

Shihezi University · CN
Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Plant-Microbe Interactions and Immunity, and RNA modifications and cancer.
h-index
58
citations
16,769
works
558
NIH funding
primary concept
Medicine
email

Recent publications

Dialogic interactions and student agency: a mixed-methods analysis of a Chinese primary school classroom guided by knowledge-building principles
Cogent Education 2026cited by 0position: contributordoi
Construction and validation of an AI agent for multistage disease-course management in diabetic foot
DOAJ (DOAJ: Directory of Open Access Journals) 2026cited by 0position: middledoi
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials
The Lancet Psychiatry 2025cited by 8position: middledoi
Research progress on the role of fascia in skin wound healing
Burns & Trauma 2025cited by 4position: middledoi
A South-South Cooperation Model: An Analysis of the Mutual Benefits of an Educational Cooperation Between China and Uruguay
2025cited by 0position: contributordoi
Research on the Construction and Application of the Mechanism Model of Interaction Behavior on Idea Depth in a Knowledge-Building Learning Community
Journal of Cases on Information Technology 2025cited by 0position: contributordoi
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
The Lancet 2024cited by 75position: middledoi
Lacticaseibacillus paracasei NCU-04 relieves constipation and the depressive-like behaviors induced by loperamide in mice through the microbiome-gut-brain axis
Current Research in Food Science 2024cited by 17position: middledoi
Linear positive association of metabolic score for insulin resistance with stroke risk among American adults: a cross-sectional analysis of National Health and Nutrition Examination Survey datasets
Journal of Stroke and Cerebrovascular Diseases 2024cited by 13position: middledoi
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial
Radiotherapy and Oncology 2024cited by 6position: middledoi
<i>Lactobacillus rhamnosus</i> LC-STH-13 ameliorates the progression of SLE in MRL/lpr mice by inhibiting the TLR9/NF-κB signaling pathway
Food & Function 2024cited by 5position: middledoi
Mechanism of the enhancement in disease resistance of citrus fruit induced by Metschnikowia citriensis treated with tryptophan
Postharvest Biology and Technology 2024cited by 5position: firstdoi
circ_0134120: a new frontier in understanding postmenopausal osteoporosis pathogenesis
Journal of Molecular Endocrinology 2024cited by 2position: middledoi
Multidisciplinary Team Quality and Improving the Survival Outcomes of Locally Advanced Rectal Cancer Patients: A Post Hoc Analysis of the Stellar Trial
SSRN Electronic Journal 2024cited by 0position: middledoi
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
Gastroenterology 2023cited by 90position: middledoi
Pressure-induced phase transition toward high symmetry in zero-strain Li<sub>2</sub>TiO<sub>3</sub>
Physical Chemistry Chemical Physics 2023cited by 2position: lastdoi
Gliotoxin Induced Ferroptosis by Downregulating SUV39H1 Expression inEsophageal Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery 2022cited by 17position: middledoi
Pushing capacities and energy densities beyond theoretical limits of lithium primary batteries using active CF<sub><i>x</i></sub> nanocapsules with <i>x</i> &gt; 1
Inorganic Chemistry Frontiers 2022cited by 15position: middledoi
Phase Transition Toward High Symmetry Above 40 GPA in Zero-Strain Li2tio3
SSRN Electronic Journal 2022cited by 0position: middledoi
Phase Transition Toward High Symmetry Above 40 GPA in Zero-Strain Li2TiO3
SSRN Electronic Journal 2022cited by 0position: middledoi
Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase
Nucleic Acids Research 2021cited by 114position: middledoi
A multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): The final reports.
Journal of Clinical Oncology 2021cited by 40position: middledoi
A pan-cancer study of spalt-like transcription factors 1/2/3/4 as therapeutic targets
Archives of Biochemistry and Biophysics 2021cited by 17position: middledoi
Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis
Gastroenterology 2020cited by 80position: middledoi
Treatment and Outcome of a Patient With Lung Cancer Infected With Severe Acute Respiratory Syndrome Coronavirus-2
Journal of Thoracic Oncology 2020cited by 66position: firstdoi
Surface curvature-confined strategy to ultrasmall nickel-molybdenum sulfide nanoflakes for highly efficient deep hydrodesulfurization
Nano Research 2020cited by 36position: middledoi
Tree-ring δ18O from Southeast China reveals monsoon precipitation and ENSO variability
Palaeogeography Palaeoclimatology Palaeoecology 2020cited by 23position: middledoi
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
New England Journal of Medicine 2019cited by 1,161position: middledoi
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis
Clinical Gastroenterology and Hepatology 2019cited by 106position: middledoi
Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study
Journal of Crohn s and Colitis 2018cited by 114position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

William J. Sandborn · Mirati Therapeutics (United States)8 papers (2013–2020)Colleen Marano · Johnson & Johnson (United States)7 papers (2013–2020) · 7 papers (2013–2019)Richard Strauß · Janssen (United States)5 papers (2013–2018)Omoniyi J. Adedokun · Johnson & Johnson (United States)5 papers (2013–2019)Brian G. Feagan · Western University5 papers (2013–2020)Bruce E. Sands · Seattle University4 papers (2018–2020)Paul Rutgeerts · KU Leuven4 papers (2013–2018) · 3 papers (2025–2026)Min Gao · Shandong University of Technology3 papers (2022–2023)Wenming Qi · Shandong University of Technology3 papers (2022–2023)Anwar Hushur · Xinjiang University3 papers (2022–2023)Katherine Li · Johnson & Johnson (United States)3 papers (2018–2020)Hadiqa Abdugopur · Xinjiang University3 papers (2022–2023)Wei Xu · Xinjiang University3 papers (2022–2023) · 3 papers (2018–2019) · 2 papers (2022–2022)María T. Abreu · Umeå University2 papers (2019–2019)Walter Reinisch · Reed Medical (United Kingdom)2 papers (2013–2018)Peter R. Gibson · Monash University2 papers (2013–2013)